Why the study?
The prevalence of concurrent cancer and severe aortic stenosis is increasing, but procedural management poses unique challenges requiring assessment of appropriateness and outcomes of TAVI in this population.
Does transcatheter aortic valve intervention improve outcomes in patients with concurrent cancer and severe aortic stenosis?
Does transcatheter aortic valve intervention improve outcomes in patients with concurrent cancer and severe aortic stenosis?
TAVI is a viable option for patients with severe AS and concurrent cancer, with outcomes largely dependent on cancer stage and survival, requiring a multidisciplinary approach.
No takes yet. Share an insight, caveat, or question.
Supports TAVI consideration via multidisciplinary evaluation in cancer patients with severe AS; leaves open randomized confirmation stratified by cancer prognosis.
Leedy et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: